POAI

Predictive Oncology Inc

POAI, USA

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

https://predictive-oncology.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
POAI
stock
POAI

Predictive Oncology Stockholders Approve Key Proposals MSN

Read more →
POAI
stock
POAI

Predictive Oncology Rebrands to Axe Compute Inc. on Nasdaq TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$3

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-0.06

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

100.29 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2,475.12 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-45,708.29 %

Low ≤ 5%

High ≥ 15%

Investors

* Institutions hold a combined 2.69% of the total shares of Predictive Oncology Inc

1.

Vanguard Group Inc

(0.6235%)

since

2025/06/30

2.

Geode Capital Management, LLC

(0.5525%)

since

2025/06/30

3.

Vanguard Institutional Extnd Mkt Idx Tr

(0.4198%)

since

2025/07/31

4.

Fidelity Extended Market Index

(0.3247%)

since

2025/07/31

5.

Virtu Financial LLC

(0.1419%)

since

2025/06/30

6.

State Street Corp

(0.121%)

since

2025/06/30

7.

Spartan Extended Market Index Pool F

(0.0916%)

since

2025/07/31

8.

Carnegie Mellon University

(0.0906%)

since

2025/06/30

9.

Fidelity Series Total Market Index

(0.086%)

since

2025/07/31

10.

Spartan Total Market Index Pool G

(0.0365%)

since

2025/07/31

11.

Fidelity Total Market Index

(0.0331%)

since

2025/07/31

12.

NT Ext Equity Mkt Idx Fd - L

(0.0306%)

since

2025/06/30

13.

Northern Trust Extended Eq Market Idx

(0.0306%)

since

2025/06/30

14.

NT Ext Equity Mkt Idx Fd - NL

(0.0157%)

since

2025/06/30

15.

State St US Extended Mkt Indx NL Cl C

(0.0153%)

since

2025/08/31

16.

Tower Research Capital LLC

(0.0132%)

since

2025/06/30

17.

Vanguard U.S. Eq Idx £ Acc

(0.0125%)

since

2025/07/31

18.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0122%)

since

2025/06/30

19.

Wells Fargo & Co

(0.0087%)

since

2025/06/30

20.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0086%)

since

2025/06/30

21.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0073%)

since

2024/12/31

22.

SSgA U.S. Total Market Index Strategy

(0.0064%)

since

2025/03/31

23.

Advisor Group Holdings, Inc.

(0.0037%)

since

2025/06/30

24.

State St US Ttl Mkt Indx NL Cl A

(0.0033%)

since

2025/08/31

25.

Bank of America Corp

(0.0007%)

since

2025/06/30

26.

Northern Trust Wilshire 5000

(0.0007%)

since

2025/06/30

27.

Royal Bank of Canada

(0.0004%)

since

2025/06/30

28.

Fidelity U.S. Equity Index Ins Trust

(0.0002%)

since

2025/07/31

29.

SBI Securities Co Ltd

(0%)

since

2025/06/30

30.

Jane Street Group LLC

(0%)

since

2025/03/31

31.

PSI Advisors, LLC

(0%)

since

2025/06/30

33.

Citigroup Inc

(0%)

since

2025/06/30

34.

UBS Group AG

(0%)

since

2025/06/30

35.

Csenge Advisory Group, LLC

(0%)

since

2025/03/31

36.

Two Sigma Investments LLC

(0%)

since

2025/03/31

37.

XTX Topco Ltd

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-107.25

EPS Estimate

—

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(0.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Wide Moat Company(6.3)
GARP
Fair GARP(4.5)
Growth
Moderate Growth(4.5)
Momentum
Moderate Momentum(5)
Net Net
Not Undervalued (Net-Net)(0.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(2.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.